Bhatia S. Late effects among survivors of leukemia during childhood and adolescence. Blood Cells Molecules and Diseases; 2003, 31(1): 84-92.

Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati BF, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group. Journal of Clinical Oncology; 2003, 21(23): 4386-4394.

Blair SL, Grant M, Chu DZ, Cullinane C, Dean G, Schwarz RE, Wagman L. Quality of life in patients with colorectal, metastasis and intrahepatic chemotherapy. Annals of Surgical Oncology; 2003, 10(2): 144-149. CCPS|DCT

Borneman T, Chu DZ, Wagman LD, Ferrell BR, Juarez G, McCahill LE, Uman G. Concerns of family caregivers of patients with cancer  facing palliative surgery for advanced malignancies. Oncology Nursing Forum; 2003, 30(6): 997-1005.

Chan JK, Monk BJ, Brewer C, Keefe KA, Osann K, McMeekin S, Rose GS, Youssef M, Wilczynski SP, Meyskens FL, Berman ML. HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. British Journal of Cancer; 2003, 89(6): 1062-1066.

Chang KL, Gaal KK, Huang Q, Weiss LM. Histiocytic lesions involving the bone marrow. Seminars in Diagnostic Pathology; 2003, 20(3): 226-236.

Chu PG, Arber DA, Weiss LM. Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. Am J Clin Pathol; 2003, 120(1): 64-70.

Chu PG, Jiang Z, Weiss LM. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol; 2003, 27(7): 952-9.

Chu PG, Weiss L, Benhattar J, Meagher VK. Intraneural synovial sarcoma. Mod Pathol; 2003; 17: 258-263.

Cullinane CA, Borneman T, Smith DD, Chu DZ, Ferrell BR, Wagman LD. The surgical treatment of cancer - A comparison of resource utilization following procedures performed with curative and palliative intent. Cancer; 2003, 98(10): 2266-2273.

Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks JC. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. Journal of the National Cancer Institute; 2003, 95(20): 1514-1521.

Ferrell B, Smith S, Cullinane C, Melancon C. Symptom concerns of women with ovarian cancer. J Pain Symptom Manage; 2003, 25(6): 528-38.

Ferrell B, Smith SL, Cullinane CA, Melancon C. Psychological well being and quality of life in ovarian cancer survivors. Cancer; 2003, 98(5): 1061-71.

Ferrell BR, Chu DZ, Wagman L, Juarez G, Borneman T, Cullinane C, McCahill LE. Patient and surgeon decision-making regarding surgery of advanced malignancies. Oncology Nursing Forum; 2003, 30(6): E106-E114.

Ferrell BR, Smith SL, Ervin KS, Itano J, Melancon C. A qualitative analysis of social concerns of women with ovarian cancer. Psychooncology; 2003, 12(7): 647-63.

Ferrell BR, Virani R, Smith S, Juarez G. The role of oncology nursing to ensure quality care for cancer survivors: a report commissioned by the National Cancer Policy Board and Institute of Medicine. Oncol Nurs Forum; 2003, 30(1): E1-E11.

Figarola JL, Scott S, Loera S, Tessler C, Chu P, Weiss L, Hardy J, Rahbar S. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia; 2003, 46(8): 1140-1152.

Fung HC, Stein F, Slovak ML, O'Donnell MR, Snyder DS, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E, Forman SJ. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: Impact of cytogenetic characteristics on transplantation outcome. Biology of Blood and Marrow Transplantation; 2003, 9(12): 766-771.

Grant M, Ferrell B. Quality of life (QOL) following bone marrow transplant (BMT) in Spanish-speaking and English-speaking survivors. Qual Life Res; 2003, 12(7): 793.

Hyman J, Wilczynski SP, Schwarz RE. Extrahepatic bile duct stricture and elevated CA 19-9: malignant or benign?. South Med J; 2003, 96(1): 89-92.

Iftner A, Klug SJ, Garbe C, Blum A, Stancu A, Wilczynski SP, Iftner T. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Research; 2003, 63(21): 7515-7519.

Im SS, Wilczynski SP, Burger RA, Monk BJ. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clinical Cancer Research; 2003, 9(11): 4145-4150.

Kadan LN, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. Jama-Journal of the American Medical Association; 2003, 290(15): 2008-2014.

Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, Lerman MI, Pfeifer GP. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res; 2003, 63(8): 1888-93.

Lau SK, Chen YY, Berry GJ, Yousem SA, Weiss LM. Epstein-Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation. Modern Pathology; 2003, 16(12): 1242-1247.

Lau S, Chen YY, Berry GJ, Yousem SA, Weiss L. No significant association of Epstein-Barr virus with fibroadenomas in immunosuppressed patients after organ transplantation. Mod Pathol; 2003; 16: 1242-1247.

Loo JC, Liu L, Hao AH, Gao LZ, Agatep R, Shennan M, Summers A, Goldstein AM, Tucker MA, Deters C, Fusaro R, Blazer K, Weitzel J, Lassam N, Lynch H, Hogg D. Germline splicing mutations of CDKN2A predispose to melanoma. Oncogene; 2003, 22(41): 6387-6394.

Matzo ML, Sherman DW, Lo K, Egan KA, Grant M, Rhome A. Strategies for teaching loss, grief, and bereavement. Nurse Educ; 2003, 28(2): 71-6.

Matzo ML, Sherman DW, Penn B, Ferrell BR. The end-of-life nursing education consortium (ELNEC) experience. Nurse Educ; 2003, 28(6): 266-70.

Matzo ML, Sherman DW, Sheehan DC, Ferrell BR, Penn B. Communication skills for end-of-life nursing care. Teaching strategies from the ELNEC curriculum. Nurs Educ Perspect; 2003, 24(4): 176-83.

Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood; 2003, 101(5): 2015-2023.

Robison LL, Bhatia S. Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence. Br J Haematol; 2003, 122(3): 345-59.

Samimi G, Varki NM, Wilczynski S, Safaei R, Alberts DS, Howell SB. Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clinical Cancer Research; 2003, 9(16): 5853-5859.

Schlake G, Liu Q, Heinmoller E, Hill KA, Weiss L, Sommer SS. Single-cell immunohistochemical mutation load assay (SCIMLA) using human paraffin-embedded tissues. Environmental and Molecular Mutagenesis; 2003, 42(3): 206-215.

Sherman DW, Matzo ML, Panke J, Grant M, Rhome A. End-of-life nursing education consortium curriculum: an introduction to palliative care. Nurse Educ; 2003, 28(3): 111-20.

Sun Y, Durrin LK, Krontiris TG. Specific interaction of PML bodies with the TP53 locus in Jurkat interphase nuclei. Genomics; 2003, 82(2): 250-2.

Tamimi RM, Hankinson SE, Ding SF, Gagalang V, Larson GP, Spiegelman D, Colditz GA, Krontiris TG, Hunter DJ. The HRAS1 variable number of tandem repeats and risk of breast cancer. Cancer Epidemiology Biomarkers & Prevention; 2003, 12(12): 1528-1530.

Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Archives of Surgery; 2003, 138(12): 1323-1328.

Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, Diller LR, Mertens AC, Whitton J, Robison LL. A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. American Journal of Epidemiology; 2003, 158(11): 1108-1113.

Lai YJ, Patel S, Katz ER. Assessing attention in children with brain tumors. Clinical Neuropsychologist; 2003, 17(1): 120-120.

Palomares MR, Goldstein L, Lehman CD, Hopper L, Gralow JR. Feasibility of breast tissue sampling in a chemoprevention trial with histologic biomarker endpoints. Breast Cancer Research and Treatment; 2003; 82: S178-S178.

McCahill LE, Smith DD, Borneman T, Juarez G, Cullinane C, Chu DZ, Ferrell BR, Wagman LD. A prospective evaluation of palliative outcomes for surgery of advanced malignancies. Annals of Surgical Oncology; 2003, 10(6): 654-663.

Ferrell B, Smith S, Juarez G, Melancon C. Meaning of Illness and Spirituality in Ovarian Cancer Survivors. Oncology Nursing Forum; 2003, 30(2): 249-257.